Peptide Comparison
Natriuretic Peptide (ANP)vsTB-500
Your heart's natural fluid and pressure regulator, helping restore balance when fluid overload strikes.
A powerful fragment of thymosin beta-4 that acts like your body's repair signal—speeding up healing of muscles, tendons, and tissues by promoting cell migration and new blood vessel growth right where you need it most.
At a Glance
Quick
comparison
Dose Range
Natriuretic Peptide (ANP)
As prescribed–As prescribed mg
TB-500
2–5 mg
Frequency
Natriuretic Peptide (ANP)
Once daily
TB-500
Twice weekly
Administration
Natriuretic Peptide (ANP)
Intravenous infusion (continuous) - standard hospital delivery method
TB-500
Subcutaneous injection
Cycle Length
Natriuretic Peptide (ANP)
Ongoing/indefinite
TB-500
4-6 weeks
Onset Speed
Natriuretic Peptide (ANP)
Moderate (1-2 weeks)
TB-500
Moderate (1-2 weeks)
Evidence Level
Natriuretic Peptide (ANP)
Moderate human trials (Phase 1-2)
TB-500
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Acute Fluid Management
Hemodynamic Stabilization
Symptom Relief
Healing Speed
Tissue Repair
Anti-Scarring
Technical Data
Compound
specifications
Natriuretic Peptide (ANP)
Molecular Formula
C127H203N45O39S3
Molecular Weight
3080.5 g/mol
Half-Life
Approximately 15-30 minutes (IV administration)
Bioavailability
100% (intravenous administration)
CAS Number
Variable depending on salt form; carperitide CAS: 120399-20-4
TB-500
Molecular Formula
C38H68N10O14
Molecular Weight
889.01 g/mol
Half-Life
2-3 days (systemic)
Bioavailability
High via subcutaneous injection (~100%)
CAS Number
885340-08-9
Protocols
Dosing
tiers
Natriuretic Peptide (ANP)
TB-500
Applications
Best
suited for
Natriuretic Peptide (ANP)
Managing acute decompensated heart failure with fluid overload
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on managing acute decompensated heart failure with fluid overload. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Relieving shortness of breath caused by pulmonary congestion
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on relieving shortness of breath caused by pulmonary congestion. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Lowering elevated blood pressure in emergency cardiac situations
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on lowering elevated blood pressure in emergency cardiac situations. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Reducing the workload on the heart during acute episodes
Natriuretic Peptide (ANP) is particularly well-suited for individuals focused on reducing the workload on the heart during acute episodes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
TB-500
Athletes Recovering from Muscle Injuries
If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal.
Tendon and Ligament Problems
Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues.
Post-Surgical Recovery
After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline.
Chronic Inflammation and Slow Healers
Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most.
Safety Profile
Side
effects
Natriuretic Peptide (ANP)
Common
- Mild discomfort at treatment site
- Hypotension (excessively low blood pressure) requiring close monitoring
- Headache and dizziness from sudden blood pressure changes
- Weakness and fatigue during or shortly after treatment
- Nausea and gastrointestinal discomfort
- Decreased kidney function temporarily, requiring follow-up monitoring
- Tremors or shaking sensations
- Atrial fibrillation (irregular heartbeat) in some patients
- Abdominal pain
- Injection site reactions if administered intravenously
- Renal dysfunction with prolonged use, especially in elderly patients
Serious
- Severe allergic reaction
TB-500
Common
- Injection site redness
- Mild fatigue or lethargy
- Mild headache
- Slight flushing
Uncommon
- Head rush or lightheadedness
- Temporary nausea
Serious
- Allergic reaction
Research Status
Safety
& evidence
Natriuretic Peptide (ANP)
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Exogenous ANP demonstrates excellent safety in Phase II/III cardiac decompensation trials with rapid clearance (2-minute half-life) providing inherent safety margins. Hypotension is the expected primary effect, managed through continuous hemodynamic monitoring and dose titration. No serious adverse events or carcinogenicity observed in 500+ trial participants. Receptor desensitization with prolonged continuous infusion requires periodic treatment breaks or dose adjustments.
Contraindications
- xSevere kidney failure with very low glomerular filtration rate
- xRecent or ongoing treatment with certain blood pressure medications that may cause dangerous drops in pressure
- xAcute coronary syndrome or recent heart attack where vasodilation could be harmful
- xSevere hypotension or cardiogenic shock without proper supportive care
- xAllergies to ANP, carperitide, or any components of the pharmaceutical formulation
TB-500
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans.
Contraindications
- xPregnancy or planning to become pregnant
- xCurrently breastfeeding
- xActive cancer or history of cancer
- xKnown allergy to peptide components
- xChildren and adolescents
Decision Guide
Which is
right for you?
Choose Natriuretic Peptide (ANP) if...
- Managing acute decompensated heart failure with fluid overload
- Relieving shortness of breath caused by pulmonary congestion
- Lowering elevated blood pressure in emergency cardiac situations
- Reducing the workload on the heart during acute episodes
Choose TB-500 if...
- Accelerating injury recovery
- Tendon and ligament healing
- Reducing chronic inflammation
- Post-surgical recovery support